UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Sillajen likely to scrap global P3 trials for Pexa-Vec
by Lee Han-soo
2019-08-02 10:29
KAIST-Hanyang University team presents new anticancer principle
by Lee Han-soo
2019-08-01 17:30
Health ministry to reimburse Novartis’ Revolade treating severe aplastic anemia
by Lee Han-soo
2019-08-01 13:36
New weight loss drug Qsymia wins local approval
by Lee Hye-seon
2019-08-01 10:57
‘Hanmi’s Carnitil improves cognitive function in patients’
by Lee Han-soo
2019-07-31 17:05
라인
Hanall marks record sales in Q2
by Lee Han-soo
2019-07-31 17:00
Novartis fails to expand heart failure drug Entresto’s indication
by Kim Yun-mi
2019-07-31 14:26
Hanmi marks ₩270.4 billion in Q2 sales
by Lee Han-soo
2019-07-30 17:26
Kolmar Korea boosts beauty, health biz through acquisitions
by Park Gi-taek
2019-07-30 14:43
GC’s Chinese partner applies for Hunter syndrome drug’s sales approval
by Lee Han-soo
2019-07-30 10:49
라인
‘FDA likely to OK 11 blockbuster candidates in August’
by Kim Yun-mi
2019-07-29 16:55
Top-30 makers produce more than half of drugs
by Lee Hye-seon
2019-07-29 16:38
Takeda’s Zejula poised to change local ovarian cancer treatment market
by Kim Yun-mi
2019-07-29 12:04
Court extends ‘temporary suspension’ of order to cancel Invossa trials
by Jeong Sae-im
2019-07-26 17:50
SNUBH professor is 1st Asian keynoter at international Alzheimer meet
by Lee Han-soo
2019-07-26 16:08
라인
‘Kolon Life Science to start following up on Invossa-treated patients’
by Lee Han-soo
2019-07-26 12:21
JW Creagene wins US patent for making dendritic cell treatment
by Lee Han-soo
2019-07-25 16:39
Merck, Pfizer launch metastatic merkel cell carcinoma treatment in Korea
by Lee Han-soo
2019-07-25 15:18
[Focus] Korean biopharmas eye US Humira market
by Jeong Sae-im
2019-07-25 15:02
Kolon Life Science ends Invossa deal with Hong Kong partner
by Lee Han-soo
2019-07-25 11:17
-
이전
31
32
33
34
35
36
37
38
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top